title: Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations.
abstract: Haemophilia A is an X-linked recessive bleeding disorder caused by heterogeneous mutations in the factor VIII gene. In an attempt to reveal the molecular pathology of Turkish haemophilia A patients, the coding sequence of the gene, excluding a large portion of exon 14, was amplified from genomic DNA and subjected to denaturing gradient gel electrophoresis prior to DNA sequencing. Fifty-nine haemophilia A patients were included in the study with severe, moderate and mild phenotypes observed in 24, 15 and 16 patients, respectively. Factor VIII activity and clinical phenotypes were not available for four patients. A total of 36 independent mutations were found, with a mutation detection efficacy of 61%. The mutations that were reported for the first time include 20 point mutations, one 8-bp insertion (TCAAGATA) in exon 4 and one large deletion greater than 2.8 kb involving exon 14. The novel point mutations were composed of three nonsense (Ser681Ter, Cys2021Ter and Gln2113Ter), one splicing error (IVS-1G-->A), 15 missense mutations (Lys48Asn; Leu-98Phe; Thr118Ala; Cys248Tyr; Glu456Lys; Asp560Ala; Tyr664Cys; Phe679Leu; Gly691Trp; Asp1769His; Val1857Leu; Gly2026Gln; Arg2163Pro; Asp2288Ala; and Arg2304Leu) and a T deletion in exon 25 that caused a frameshift followed by a stop codon. All missense mutations except Val1857Leu, which maintained a conserved nonpolar R group, occurred at amino acids conserved among four species and were most probably pathogenic. In addition, two sequence changes (IVS3-9C-->T) and (Leu2230Leu) were also detected in patients carrying Val1857Leu and Phe679Leu missense mutations, respectively. Identification of mutation origins in eight sporadic cases revealed an equal sex ratio of mutations.
authors.affiliation: Department of Molecular Biology and Genetics, Bogaziçi University, 80815 Bebek, Istanbul, Turkey.
authors.forename: A A
authors.initials: AA
authors.lastname: Timur
authors.forename: A
authors.initials: A
authors.lastname: Gürgey
authors.forename: G
authors.initials: G
authors.lastname: Aktuglu
authors.forename: K
authors.initials: K
authors.lastname: Kavakli
authors.forename: D
authors.initials: D
authors.lastname: Canatan
authors.forename: K
authors.initials: K
authors.lastname: Olek
authors.forename: S H
authors.initials: SH
authors.lastname: Caglayan
mesh_terms: D004252:DNA Mutational Analysis; D005169:Factor VIII / Q000235:genetics; D005192:Family Health; D006467:Hemophilia A / Q000453:epidemiology* / Q000235:genetics*; D006801:Humans; D008403:Mass Screening; D009154:Mutation; D010641:Phenotype; D012737:Sex Factors; D014421:Turkey / Q000453:epidemiology
chemical_list: D005169:Factor VIII